Anti-Cardiolipin Antibody (IgG) with High-Sensitivity Immunoassay
This test measures the presence of antibodies against cardiolipin, a phospholipid found in cell membranes, often used to evaluate for lupus anticoagulant or antiphospholipid syndrome.
["This test helps assess potential blood clotting issues or autoimmune conditions."]
Key facts at a glance
- LOINC
- 58761-8
- Short code
- CBUR2G
- Synonyms
- C burnet Ph2 IgG Titr CSF IF
- Category
- chemistry
- Sample
- csf
- Container
- Sterile, leak-proof, screw-cap cryovial or CSF collection tube (polypropylene preferred). Tubes should be free of preservatives that may interfere with immunofluorescence detection.
- Units
- N/A
- Ref low
- 0
- Ref high
- 1
- Critical range
- — – 128 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Immunofluorescence Assay (IFA)
- CPT
- 86638
- SNOMED
- 122460008
- Specimen volume
- Minimum 0.5 mL of cerebrospinal fluid; optimal volume 1.0–2.0 mL
- Stability
- Room temperature: 2 hours; Refrigerated (2–8°C): 7 days; Frozen (-20°C or below): up to 30 days. Avoid repeated freeze-thaw cycles. Ship on cold packs if not delivered same day.
- Hemolysis max
- 200
- TAT
- 48–96 hours
- Order
- routine
What This Test Measures
Anti-cardiolipin antibodies are proteins your immune system produces in response to certain phospholipids in your blood. High levels may suggest an autoimmune condition or increased risk of blood clots, though they are not definitive on their own.
Why It Might Be Ordered
Your healthcare provider may recommend this test if you have symptoms like unexplained blood clots, recurrent miscarriages, or other signs of antiphospholipid syndrome. It may also be part of a broader evaluation for conditions like lupus or other autoimmune disorders.
What to Expect Before the Test
No special preparation is needed unless instructed by your provider. You may have blood drawn from a vein in your arm, similar to other routine blood tests.
What the Results Mean
Results are typically reported as positive or negative for IgG antibodies. Elevated levels may indicate an increased risk of clotting or autoimmune activity, but further testing and clinical correlation are needed for diagnosis.
Reference range
Titer <1:16: Negative (no detectable antibodies); Titer 1:16–1:64: Equivocal/borderline; Titer ≥1:128: Positive, suggestive of past exposure or chronic Q fever infectionN/A
No special patient preparation is required. Inform the ordering physician of any recent antibiotic therapy, as it may affect antibody titers. Lumbar puncture should be performed under sterile conditions by qualified personnel.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Positive results for anti-cardiolipin antibodies can be associated with antiphospholipid syndrome, a condition linked to an increased risk of blood clots and pregnancy complications. They may also appear in other autoimmune diseases like lupus. However, they are not alone sufficient for diagnosis; additional tests and clinical findings are required.
Short name
Anti-Cardiolipin IgG (High-Sensitivity)
Frequently asked questions
What does a positive result mean?
Can this test be done at home?
How often should I get this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy